The Journal of Immunology, Vol 154, Issue 9 4434-4443, Copyright © 1995 by American Association of Immunologists

ARTICLES

V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene

CL Ruegg, A Rivas, ND Madani, J Zeitung, R Laus and EG Engleman
Department of Pathology, Stanford University School of Medicine, CA 94305, USA.

V7 is a cell surface glycoprotein expressed on Ag-activated T cells, monocytes, and granulocytes, as well as subpopulations of T cells and accessory cells present in thymic medulla and tonsil. A mAb directed against V7 inhibits the proliferative response of T cells to allogeneic cells or immobilized anti-CD3 Ab, but not lectin mitogens, suggesting that V7 plays a role in TCR/CD3-mediated T cell activation. We have used the anti-V7 Ab in eukaryotic expression cloning experiments to isolate a cDNA clone containing a 3,340-bp insert that encodes V7 when transiently expressed in simian and murine fibroblastoid cells. DNA sequence analysis revealed a novel 1,021-amino acid open reading frame the structure of which conforms to the category of type I integral membrane proteins. The protein sequence includes a 20-residue putative hydrophobic signal sequence followed by a putative extracellular domain of 934 amino acids, a prototypic hydrophobic transmembrane spanning a domain of 25 residues, and finally a short and highly charged putative cytoplasmic domain of 42 residues. The extracellular domain contains seven pairs of regularly spaced cysteine residues, suggestive of Ig- like domains. On the basis of statistical analysis of the sequences of the putative cysteine loops, all seven of the Ig-like domains belong to the variable, or V-type, category. By using fluorescence in situ hybridization, we have mapped the V7 gene to human chromosome Ip13. Thus, the V7 glycoprotein represents a novel member of the Ig superfamily that is involved in critical intracellular signals essential for immune function.

This article has been cited by other articles:

				I. Fernandez, R. Zeiser, H. Karsunky, N. Kambham, A. Beilhack, K. Soderstrom, R. S. Negrin, and E. Engleman CD101 Surface Expression Discriminates Potency Among Murine FoxP3+ Regulatory T Cells J. Immunol., September 1, 2007; 179(5): 2808 - 2814. [Abstract] [Full Text] [PDF]

				X. A. Zhang, W. S. Lane, S. Charrin, E. Rubinstein, and L. Liu EWI2/PGRL Associates with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration of Prostate Cancer Cells Cancer Res., May 15, 2003; 63(10): 2665 - 2674. [Abstract] [Full Text] [PDF]

				L. Edelmann, R. K. Pandita, E. Spiteri, B. Funke, R. Goldberg, N. Palanisamy, R. S. K. Chaganti, E. Magenis, R. J. Shprintzen, and B. E. Morrow A common molecular basis for rearrangement disorders on chromosome 22q11 Hum. Mol. Genet., July 1, 1999; 8(7): 1157 - 1167. [Abstract] [Full Text] [PDF]

				L. R. B. Soares, L. Tsavaler, A. Rivas, and E. G. Engleman V7 (CD101) Ligation Inhibits TCR/CD3-Induced IL-2 Production by Blocking Ca2+ Flux and Nuclear Factor of Activated T Cell Nuclear Translocation J. Immunol., July 1, 1998; 161(1): 209 - 217. [Abstract] [Full Text] [PDF]

				D. J. Orlicky, J. G. Lieber, C. L. Morin, and R. M. Evans Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells J. Lipid Res., June 1, 1998; 39(6): 1152 - 1161. [Abstract] [Full Text]

				P. D. Sherrington, J. L. Scott, B. Jin, D. Simmons, D. J. Dorahy, J. Lloyd, J. H. Brien, R. H. Aebersold, J. Adamson, M. Zuzel, et al. TLiSA1 (PTA1) Activation Antigen Implicated in T Cell Differentiation and Platelet Activation Is a Member of the Immunoglobulin Superfamily Exhibiting Distinctive Regulation of Expression J. Biol. Chem., August 29, 1997; 272(35): 21735 - 21744. [Abstract] [Full Text] [PDF]